AU4054299A - Human mp52 gene promoter and method for exploring useful substance by using the same - Google Patents

Human mp52 gene promoter and method for exploring useful substance by using the same

Info

Publication number
AU4054299A
AU4054299A AU40542/99A AU4054299A AU4054299A AU 4054299 A AU4054299 A AU 4054299A AU 40542/99 A AU40542/99 A AU 40542/99A AU 4054299 A AU4054299 A AU 4054299A AU 4054299 A AU4054299 A AU 4054299A
Authority
AU
Australia
Prior art keywords
human
same
gene promoter
useful substance
exploring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40542/99A
Inventor
Gertrud Hotten
Shinji Kawai
Takeyuki Sugiura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Nippon Hoechst Marion Roussel Ltd
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Hoechst Marion Roussel Ltd, Hoechst Marion Roussel Inc filed Critical Nippon Hoechst Marion Roussel Ltd
Publication of AU4054299A publication Critical patent/AU4054299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU40542/99A 1998-06-18 1999-06-11 Human mp52 gene promoter and method for exploring useful substance by using the same Abandoned AU4054299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/170941 1998-06-18
JP10170941A JP2000004882A (en) 1998-06-18 1998-06-18 Human mp52 gene promotor and screening of useful substance using the same
PCT/IB1999/001071 WO1999066060A1 (en) 1998-06-18 1999-06-11 Human mp52 gene promoter and method for exploring useful substance by using the same

Publications (1)

Publication Number Publication Date
AU4054299A true AU4054299A (en) 2000-01-05

Family

ID=15914215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40542/99A Abandoned AU4054299A (en) 1998-06-18 1999-06-11 Human mp52 gene promoter and method for exploring useful substance by using the same

Country Status (4)

Country Link
EP (1) EP1086238A1 (en)
JP (2) JP2000004882A (en)
AU (1) AU4054299A (en)
WO (1) WO1999066060A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US7811793B2 (en) 1996-12-25 2010-10-12 Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Process for preparing purified active monomer of bone-derived factor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525416A1 (en) * 1995-07-12 1997-01-16 Bioph Biotech Entw Pharm Gmbh Use of MP52 for the treatment and prevention of diseases of the nervous system
IL110589A0 (en) * 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
JPH0931098A (en) * 1995-07-24 1997-02-04 Hoechst Japan Ltd New protein hmw human mp52
CA2235481A1 (en) * 1995-10-23 1997-05-01 Sean M. Kerwin Compositions and methods for treating bone deficit conditions
US6159696A (en) * 1996-11-22 2000-12-12 Akzo Nobel N.V. Isolated human BMP-4 promoter region

Also Published As

Publication number Publication date
JP2000004882A (en) 2000-01-11
JP2002518019A (en) 2002-06-25
EP1086238A1 (en) 2001-03-28
WO1999066060A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
AU8495198A (en) Water-stabilized organosilane compounds and methods for using the same
AU6462098A (en) Compounds useful as electrodes and method for preparing same
AU7837898A (en) Method for measuring myocardial motion and the like
AU3591295A (en) Personal comfort apparatus
AU1380699A (en) Composition and method for increasing insulin activity
AU4950997A (en) Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
IL139100A0 (en) Human bmp-7 promoter and method for exploring bone-related substance by using the same
AU7063300A (en) Method and apparatus for predicting the risk of hypoglycemia
AUPP108697A0 (en) Apparatus for electrophoresis
AU6182098A (en) System and method for coordinating potential employers and candidates for employment
AU7755398A (en) Method for reducing body weight
AU2205099A (en) Chimeric proteins for the treatment of diabetes
AU3163599A (en) Human bmp-2 promoter and method for exploring bone-related substance by using the same
AU2163299A (en) Method for inhaling powdery substances
AU5784398A (en) Method for the rejuvenation of the neck-face skin structure
AU5417398A (en) Computer control apparatus
AU4054299A (en) Human mp52 gene promoter and method for exploring useful substance by using the same
AU9399798A (en) Methods for regulating trka expression
AU5649299A (en) Protein solution preparation and method for stabilizing the same
AU1144399A (en) Method for the control of biodegradation
PL344526A1 (en) Human bmp-4 promoter and method for exploring bone-related substance by using the same
EP1028626A4 (en) Method for the augmentation of gene expression
AU7109698A (en) A nitrobenzylmercaptopurineriboside (nbmpr)-insensitive, equilibrative, nucleoside transport protein, nucleic acids encoding the same and methods of use
AU7364798A (en) Isolated melanin-like substance and method for producing the same
AUPO933597A0 (en) Diagnostic method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase